3. Son Y, Lee HJ, Rho JK, et al. The ameliorative effect of silibinin against radiation-induced lung injury: protection of normal tissue without decreasing therapeutic efficacy in lung cancer. BMC Pulm Med. 2015, 15: 68.
[3]
10. Carter CL, Jones JW, Barrow K, et al. A MALDI-MSI Approach to the Characterization of Radiation-Induced Lung Injury and Medical Countermeasure Development.Health Phys. 2015, 109(5): 466-478.
[4]
15. Zhang J, Li B, Ding X, et al. Genetic variants in inducible nitric oxide synthase gene are associated with the risk of radiation-induced lung injury in lung cancer patients receiving definitive thoracic radiation. Radiother Oncol. 2014, 111(2): 194-198.
[5]
16. Yu J, Yuan X, Liu Y, et al. Delayed Administration of WP1066, an STAT3 Inhibitor, Ameliorates Radiation-Induced Lung Injury in Mice. Lung. 2016, 194(1): 67-74.
[6]
17. Zhao DY, Qu HJ, Guo JM, et al. Protective Effects of Myrtol Standardized Against Radiation-Induced Lung Injury. Cell Physiol Biochem. 2016, 38(2): 619-634.
[7]
18. Kralj E, Zakelj S, Trontelj J, et al. Absorption and elimiation of imatinib through the rat intestine in vitro. Int J Pharm, 2014, 460(1/2): 144-149.
[8]
19. Quinta’s-Cardama A, Jabbour EJ. Considerations for early switch to nilotinib or dasatinib in patients with chronic myeloid leukemia with inadequate response to first-line imatinib. Leuk Res, 2013, 37(5): 487-495.
[9]
20. Liu Y, Tan D, Tong C, et al. Blueberry anthocyanins ameliorate radiation-induced lung injury through the protein kinase RNA-activated pathway. Chem Biol Interact. 2015, 242:363-371.
[10]
2. Li X, Xu G, Qiao T, et al. Effects of CpG oligodeoxynucleotide 1826 on acute radiation-induced lung injury in mice. Biol Res. 2016, 49(1): 8.
[11]
4. Fang XM, Hu CH, Hu XY, et al. An Appreciation for the Rabbit Ladderlike Modeling of Radiation-induced Lung Injury with High-energy X-Ray. Chin Med J (Engl). 2015, 128(12): 1636-1642.
[12]
5. Malaviya R, Gow AJ, Francis M, et al. Radiation-induced lung injury and inflammation in mice: role of inducible nitric oxide synthase and surfactant protein D. Toxicol Sci. 2015, 144(1): 27-38.
[13]
6. Elias MH, Bada AA, Azlan H, et al. BCＲ-ABL kinase domain mutations, including 2 novel mutations inimatinib resistant Malaysian chronic myeloid leukemia patients-Frequency and clinical Outcome. Leuk Res, 2014, 38(4): 454-459.
[14]
7. Mathisen MS, Kantarjian HM, Cortes J, et al. Practical issues surrounding the explosion of tyrosine kinase inhibitors for the management of chronic myeloid leukemia. Blood Rev, 2014, 28(5): 179-187.
[15]
8. 孙敬方. 动物实验方法学. 北京: 人民卫生出版社, 2001, 198-201.
[16]
9. Jiao J, Gai QY, Zhang L, et al. High-speed homogenization coupled with microwave-assisted extraction followed by liquid chromatography-tandem mass spectrometry for the direct determination of alkaloids and flavonoids in fresh Isatis tinctoria L. hairy root cultures. Anal Bioanal Chem. 2015, 407(16): 4841-4848.
[17]
11. Giridhar P, Mallick S, Rath GK, et al. Radiation induced lung injury: prediction, assessment and management. Asian Pac J Cancer Prev. 2015, 16(7): 2613-2617.
[18]
12. Santyr G, Fox M, Thind K, et al. Anatomical, functional and metabolic imaging of radiation-induced lung injury using hyperpolarized MRI. NMR Biomed. 2014, 27(12): 1515-1524.
[19]
13. Murigi FN, Mohindra P, Hung C, et al. Dose Optimization Study of AEOL 10150 as a Mitigator of Radiation-Induced Lung Injury in CBA/J Mice. Radiat Res. 2015, 184(4): 422-432. doi: 10.1667/RR14110.1.
[20]
14. Huang Y, Liu W, Liu H, et al. Grape seed pro-anthocyanidins ameliorates radiation-induced lung injury. J Cell Mol Med. 2014, 18(7): 1267-1277.
